SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of $17.00...
Hence then, the article about immune mediated disease therapeutics developer attovia therapeutics debuts on nasdaq was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq )
Also on site :
- 1975 Rock Ballad, 'One of Pop Music's Saddest Songs,' Was Inspired by a Heartbreak That Wouldn't Heal
- Dolly Parton’s $11 Dish Towel Set Has the Sweetest Butterfly Design That’ll Bring a Touch of Country Charm to Your Home
- FX's The Shards: Which Parts Of Bret Easton Ellis' Story Actually Happened — And What Did He Make Up?